Methyl-MMDA-2

Methyl-MMDA-2
Systematic (IUPAC) name
N-methyl-1-(6-methoxy-1,3-benzodioxol-5-yl)propan-2-amine
Clinical data
Legal status
Routes of
administration
Oral, Insufflated, Rectal
Identifiers
CAS Number ?
ATC code None
PubChem CID ?
ChemSpider 23553107
Chemical data
Formula C12H17NO3
Molar mass 223.27 g/mol

N-Methyl-2-methoxy-4,5-methylenedioxyamphetamine (methyl-MMDA-2; 6-methoxy-MDMA) is a psychedelic drug of the amphetamine class.[1] It is the N-methylated derivative of MMDA-2, and is also an analog of MDMA and 6-methyl-MDA.[1]

Methyl-MMDA-2 was first synthesized by Alexander Shulgin and was described in his book PiHKAL. He states that it is essentially inactive at a dose of 70 mg, and he did not try any higher;[1] however, Methyl-MMDA-2 is still likely to be active, perhaps in the 125-250 mg range. This reduction in hallucinogenic activity relative to MMDA-2 parallels that of MDA and MDMA, indicating that with phenethylamines, N-methylation substantially reduces 5-HT2A receptor affinity.[1][2]

See also

References

  1. 1 2 3 4 Ann Shulgin; Alexander Shulgin (1991). Pihkal: A Chemical Love Story. Transform Press. ISBN 0-9630096-0-5.
  2. Nichols DE, Oberlender R (1989). "Structure-activity relationships of MDMA-like substances". NIDA Research Monograph 94: 1–29. PMID 2575223.

External links

This article is issued from Wikipedia - version of the Friday, September 18, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.